Transcriptional regulatory landscapes underlying FEZ Formation

自由经济区形成的转录监管格局

基本信息

项目摘要

Summary: Morphogenesis of vertebrate tissues and organs occurs through well-orchestrated tissue interactions. During development of the upper jaw, signaling interactions among the forebrain, the facial ectoderm, and the intervening neural crest cells regulate development of the upper jaw. Our research has revealed that signals from the brain and the neural crest cells act together to induce expression of Sonic hedgehog (SHH) in the Frontonasal Ectodermal Zone (FEZ), a signaling center located in the surface ectoderm of the Frontonasal Process (FNP) that directs patterned growth of the upper jaw anlagen. Our preliminary data also suggest that Pre-B-cell leukemia homeobox (PBX) transcription factors are involved in inducing and maintaining the pattern of SHH expression in the FEZ by an interacting genetic network. The research proposed in this application is designed to uncover the gene regulatory mechanisms that are activated by signals from the forebrain and the neural crest, as well as, to investigate the role of PBX transcription factors in regulating SHH expression in the FEZ. Specifically, we hypothesize that 1) SHH signaling from the forebrain induces “competence” in surface ectoderm cells to express SHH; 2) subsequently, upon arrival, neural crest cells induce transcription of SHH in competent cells of the FEZ, and 3) PBX transcription factors participate in regulating expression of SHH in the FEZ. We will test this hypothesis in three specific aims using avian and murine embryos. In each Aim, we will use chick embryos because they allow us to manipulate the signaling interactions between the brain and the FEZ (Aim 1), the neural crest cells and the ectoderm (Aim 2), or expression of PBX1 and PBX3 (Aim 3). We will use a variety of genomic approaches (ATAC-seq, ChIP-seq, GRO-seq) to evaluate changes in chromatin and activated transcriptional regulatory elements (TREs) at the SHH locus. In Aim 3, we will also assess morphological, cellular, and molecular outcomes of altering PBX gene expression, and we will use mouse embryos to take advantage of data already generated in the Selleri laboratory. The results of the work proposed in this application will shed light on the molecular aspects of facial development, and will aid understanding of disease processes that occur in this region. Allelic variants in SHH, or SHH pathway members, are associated with human dysmorphologies of the craniofacial complex in diseases such as Holoprosencephaly and cleft lip with our without cleft palate. Recently, PBX genes have been identified as risk variants in patients with craniofacial dysmorphology. Hence, our innovative approach combining studies with a solid foundation in developmental biology with chromatin analyses will yield information that is directly applicable to understanding human dysmorphology.
简介:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RALPH S MARCUCIO其他文献

RALPH S MARCUCIO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RALPH S MARCUCIO', 18)}}的其他基金

Cell Transitions during Bone Fracture Healing
骨折愈合过程中的细胞转变
  • 批准号:
    10754205
  • 财政年份:
    2023
  • 资助金额:
    $ 4.57万
  • 项目类别:
Transcriptional regulatory landscapes underlying FEZ Formation
自由经济区形成的转录监管格局
  • 批准号:
    10358628
  • 财政年份:
    2020
  • 资助金额:
    $ 4.57万
  • 项目类别:
Transcriptional regulatory landscapes underlying FEZ Formation
自由经济区形成的转录监管格局
  • 批准号:
    10581562
  • 财政年份:
    2020
  • 资助金额:
    $ 4.57万
  • 项目类别:
Transcriptional regulatory landscapes underlying FEZ Formation
自由经济区形成的转录监管格局
  • 批准号:
    10577995
  • 财政年份:
    2020
  • 资助金额:
    $ 4.57万
  • 项目类别:
Effects of Aging on Macrophages and Bone Regeneration
衰老对巨噬细胞和骨再生的影响
  • 批准号:
    8738567
  • 财政年份:
    2013
  • 资助金额:
    $ 4.57万
  • 项目类别:
Effects of Aging on Macrophages and Bone Regeneration
衰老对巨噬细胞和骨再生的影响
  • 批准号:
    8881043
  • 财政年份:
    2013
  • 资助金额:
    $ 4.57万
  • 项目类别:
Effects of Aging on Macrophages and Bone Regeneration
衰老对巨噬细胞和骨再生的影响
  • 批准号:
    9069665
  • 财政年份:
    2013
  • 资助金额:
    $ 4.57万
  • 项目类别:
Effects of Aging on Macrophages and Bone Regeneration
衰老对巨噬细胞和骨再生的影响
  • 批准号:
    8616534
  • 财政年份:
    2013
  • 资助金额:
    $ 4.57万
  • 项目类别:
MOLECULAR BASIS OF TISSUE INTERACTIONS THAT REGULATE CRANIOFACIAL DEVELOPMENT
调节颅面发育的组织相互作用的分子基础
  • 批准号:
    7249157
  • 财政年份:
    2007
  • 资助金额:
    $ 4.57万
  • 项目类别:
MOLECULAR BASIS OF TISSUE INTERACTIONS THAT REGULATE CRANIOFACIAL DEVELOPMENT
调节颅面发育的组织相互作用的分子基础
  • 批准号:
    7418921
  • 财政年份:
    2007
  • 资助金额:
    $ 4.57万
  • 项目类别:

相似海外基金

Combinatorial targeting for the treatment of B-cell acute lymphoblastic leukemia
治疗 B 细胞急性淋巴细胞白血病的组合靶向
  • 批准号:
    10973162
  • 财政年份:
    2023
  • 资助金额:
    $ 4.57万
  • 项目类别:
Optimizing outcomes for children and young adults with relapse of B-cell acute lymphoblastic leukemia after CD19-targeted chimeric antigen receptor T-cell therapy
优化 CD19 靶向嵌合抗原受体 T 细胞治疗后 B 细胞急性淋巴细胞白血病复发的儿童和年轻人的结局
  • 批准号:
    10572071
  • 财政年份:
    2023
  • 资助金额:
    $ 4.57万
  • 项目类别:
A Phase I trial of single domain antibody-based CD22 chimeric antigen receptor (CAR)-T cells for the treatment of relapsed/refractory CD22+ B-cell acute lymphoblastic leukemia
基于单域抗体的 CD22 嵌合抗原受体 (CAR)-T 细胞治疗复发/难治性 CD22 B 细胞急性淋巴细胞白血病的 I 期试验
  • 批准号:
    466359
  • 财政年份:
    2022
  • 资助金额:
    $ 4.57万
  • 项目类别:
    Operating Grants
Dissecting the Functional Role of Monocytes in B-cell Acute Lymphoblastic Leukemia Survival
剖析单核细胞在 B 细胞急性淋巴细胞白血病生存中的功能作用
  • 批准号:
    10621136
  • 财政年份:
    2022
  • 资助金额:
    $ 4.57万
  • 项目类别:
A Phase I trial of single domain antibody-based CD22 chimeric antigen receptor (CAR)-T cells for the treatment of relapsed/refractory CD22+ B-cell acute lymphoblastic leukemia
基于单域抗体的 CD22 嵌合抗原受体 (CAR)-T 细胞治疗复发/难治性 CD22 B 细胞急性淋巴细胞白血病的 I 期试验
  • 批准号:
    474613
  • 财政年份:
    2022
  • 资助金额:
    $ 4.57万
  • 项目类别:
    Operating Grants
Role of ETS Translocation Variant 5 (ETV5) in B Cell Acute Lymphoblastic Leukemia
ETS 易位变异体 5 (ETV5) 在 B 细胞急性淋巴细胞白血病中的作用
  • 批准号:
    486078
  • 财政年份:
    2022
  • 资助金额:
    $ 4.57万
  • 项目类别:
    Studentship Programs
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
PI3K 抑制预防 B 细胞急性淋巴细胞白血病复发的新用途
  • 批准号:
    10455633
  • 财政年份:
    2021
  • 资助金额:
    $ 4.57万
  • 项目类别:
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
PI3K 抑制预防 B 细胞急性淋巴细胞白血病复发的新用途
  • 批准号:
    10289183
  • 财政年份:
    2021
  • 资助金额:
    $ 4.57万
  • 项目类别:
Mitochondrial Metabolism as a Therapeutic Target for Relapsed B-cell Acute Lymphoblastic Leukemia
线粒体代谢作为复发 B 细胞急性淋巴细胞白血病的治疗靶点
  • 批准号:
    449447
  • 财政年份:
    2020
  • 资助金额:
    $ 4.57万
  • 项目类别:
    Studentship Programs
Mechanisms of driver mutation cooperativity in precursor B cell acute lymphoblastic leukemia
前体B细胞急性淋巴细胞白血病驱动突变协同机制
  • 批准号:
    408514
  • 财政年份:
    2019
  • 资助金额:
    $ 4.57万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了